Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4518_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
30 Мб
Скачать
a
b
9 Sleep-Disordered Breathing andObstructive Sleep Apnea
https://t.me/medicina_free
147
Fig. 9.1 (a, b) Obstructive apnea
148
https://t.me/medicina_free
Fig. 9.2 Central apnea
E. C. Kinberg et al.
Fig. 9.3 Mixed apnea
9 Sleep-Disordered Breathing andObstructive Sleep Apnea
https://t.me/medicina_free
Fig. 9.4 Hypopnea
149
Fig. 9.5 Alpha activity on EEG
Fig. 9.6 Theta waves
150
https://t.me/medicina_free
Fig. 9.7 Sleep spindles
Fig. 9.8 K complexes
E. C. Kinberg et al.
Fig. 9.9 Delta waves
Treatment
Medical
• Conservative/behavioral modications
– Avoid alcohol, sedatives at bedtime
Sedatives can promote deep sleep, make apnea more pronounced, blunt drive to arouse and resume breathing
9 Sleep-Disordered Breathing andObstructive Sleep Apnea
https://t.me/medicina_free
– Weight loss – Positional therapy: supine position, tongue falls posteriorly enhancing
obstruction
– Bariatric surgery consult for morbidly obese patients
• CPAP (continuous positive airway pressure): gold standard
– Pneumatic splint, prevents upper airway collapse, constant intraluminal pres-
sure during inspiration and expiration
– Moderate-to-severe OSA
Reduces AHI, improved subjective and objective sleep measures, quality of life measures, decreased cardiovascular events, decreased MVAs
– Complicated by patient adherence
Compliance considered at least 4 h per night, 5 days/week
• BiPAP
– Separately adjustable lower expiratory and higher inspiratory PAP: tolerated
better by some
• APAP (Autoadjusting PAP)
– Autotitrate PAP to select an effective level of CPAP to prevent upper airway
collapse. – Pressure changes in response to variations, snoring, impedence. – Consistently high pressures can induce central apneas and are therefore
suboptimal.
151
• Oral appliances
– Mild-to-moderate OSA – Mobilizes mandible and base of tongue anteriorly, maintains patency of pos-
terior oropharyngeal airway – Complicated by tooth/jaw pain, increase in salivation overnight, dry mouth – Cost-effective but more effective for milder cases
• Medications
– Insufcient evidence. Theory: increase upper airway dilator muscle tone,
increase ventilatory drive, increase cholinergic tone during sleep versus a
decrease in percent of REM sleep, decreased airway resistance, decreased
surface tension in the upper airway – Progesterone: respiratory stimulant – Acetazolamide: increases hydrogen concentration in blood – Theophylline: increases hypoxic ventilatory drive – Protryptiline: reduce REM sleep
152
https://t.me/medicina_free
E. C. Kinberg et al.
– Oxygen therapy – Fluticasone: if allergic rhinitis component – Montelukast (leukotriene receptor antagonist): decreased adenoid size in chil-
dren with mild OSA – Modanil (central post alpha-adrenergic receptor): promotes alertness, used
to treat narcolepsy and idiopathic hypersomnia, adjuvant for patients on
CPAP who continue to experience excessive daytime sleepiness – Nasal strips
Can decrease snoring, mouth breathing, and sleepiness Can improve UPPP selection/outcomes
Surgical: determined by the site of obstruction
• Counseling possibility of multiple or staged procedures, possibility of tracheostomy
• Nasal: can reduce CPAP pressurerequirements, rarely cures OSA
– Septoplasty – Turbinate surgery – Nasal valve repair – Sinus surgery – Adenoidectomy
• Palatal
– UPPP with or without tonsillectomy
Remove uvula, redundant tissue from the soft palate and anterior tonsil­lar pillars Posterior tonsillar pillars advanced lateral-cephalad direction Enlarge nasopharyngeal airway in anterior to posterior dimension Risk of nasal reux temporarily, infection, change in speech
– Transpalatal advancement pharyngoplasty after UPPP if persistent OSA
Remove 1cm of the hard palate, advance the soft palate, secure to tensor aponeurosis
– Expansion sphincteroplasty
Variation of UPPP
– Uvulopalatal ap
Variation of UPPP Advancement ap, suture uvula, and distal soft palatal tissue upward onto soft palate If VPI, procedure is reversible Contraindicated in patients with excessively thick palates or uvulas
9 Sleep-Disordered Breathing andObstructive Sleep Apnea
https://t.me/medicina_free
– Z-palatoplasty – Laser-assisted uvulopalatoplasty (LAUP)
Primarily for snoring CO2 laser, 2 vertical cuts in soft palate on either side of uvula, amputate lower two-thirds to three-fourths of the uvulaScar retraction and stiffening of the palate is achieved
– Cautery-assisted palatal stiffening (CAPSO)
Remove mucosa off midline of soft palate, induces scar tissue resulting in stiffer palate
– Radiofrequency ablation of soft palate
Soft palate coagulation necrosis causes scarring and contraction of tissue, shorter stiffer soft palate Ofce-based procedure, local anesthesia
– Palate implant
Used for snoring 3 to 5 implantable rods inserted into the palate for scar formation Risk of implant extrusion
– Injection snoreplasty
153
Ofce-based procedure for snoring
Inject sclerosing agent (alcohol, sodium tetradecyl sulfate) into midline of
soft palate
The Friedman criteria were developed to predict the success of a UPPP for indi-
vidual patients (Fig.9.10)
• Stage 1: 80%
• Stage 2: 40%
• Stage 3: 8%
Palate Tonsil BMI
Stage I 1 3, 4 <40
2 3, 4 <40
Stage II 1, 2 0, 1, 2 <40
3, 4 3, 4 <40
Stage III 3 0, 1, 2 Any
4 0, 1, 2 Any Any Any >40
154
https://t.me/medicina_free
E. C. Kinberg et al.
Fig. 9.10 Left modied Friedman tonsil classication. 0 surgically removed tonsils, I tonsils hidden within tonsil pillars, II tonsils extending to the pillars, III
tonsils extending 3/4 of the way to the midline, IV tonsils completely obstructed. Right modied malampatti classication. I tonsils, pillars, and soft palate are
clearly visible; II uvula, pillars, and upper pole are visible; III only part of soft palate is visible; IV soft palate is not visible
9 Sleep-Disordered Breathing andObstructive Sleep Apnea
https://t.me/medicina_free
To keep the staging simple:
1. Maximum BMI for a stage 1 or 2 patient is 40.
2. If the tonsils are size 3 or 4, the patient is stage 1.
(a) Exception: if the palate is also a 3 or 4, then its stage 2.
3. If the BMI is > 40, the patient is stage III.
• Tongue base
– Partial midline glossectomy
CO2 laser, electrocautery, plasma knife, coblation Risk of bleeding from lingual artery, hypoglossal nerve injury, hematoma, abscess, dysphagia, taste disturbance
– Lingualplasty – Lingual tonsillectomy – Radiofrequency tongue base ablation
Four lesions at circumvallate papilla to reduce tissue volume at the tongue base
• Hypopharyngeal
– Genioglossus advancement
155
More anteriorly positioned tongue with increased tension on the genioglossus Rectangular geniotubercle osteotomy with advancement Risk of dental root injury, mandible fracture, hematoma
– Hyoid myotomy/suspension
Hyoid mobilized anteriorly and superiorly via attachment to the mandible or to thyroid cartilage Risk of numbness, infection, seroma, fracture, death
– Tongue suspension
Base of tongue to anterior oor of mouth
– Maxillomandibular advancement
Most effective surgical procedure for OSA Enlarges pharyngeal and hypopharyngeal airway Risk of malocclusion, relapse, nerve paresthesia, nonunion, malunion, temporomandibular joint tenderness, infection
• Tracheotomy
– Bypass the site of upper airway obstruction – Indications: morbid obesity, arrhythmia with apnea, severe apnea with desatu-
ration, cor pulmonale, no response to dietary modications or CPAP, chronic alveolar hypoventilation
156
https://t.me/medicina_free
Postoperative care
• There is an increased risk of airway compromise from edema, respiratory rate alteration secondary to narcotics, possibility of bleeding and difculty with intubation
• Repeat polysomnography at 3–4 months postoperatively
E. C. Kinberg et al.
Upper Airway Stimulation (UAS; Hypoglossal Nerve Stimulators)
Electrical stimulators are implanted and connected to pleural sensing leads. The stimulators activate pharyngeal dilators during the inspiratory phase of respiration.
Focused stimulation produces the most signicant clinical outcomes.
• Tongue protruders: genioglossus
– Innervated by medial branch of CNXII
• Tongue retractors: hyoglossus, styloglossus
– Innervated by lateral (C1) branch of CNXII
FDA approved indications:
• Moderate-to-severe sleep apnea (AHI range: 15–65).
• Age: 18 and older.
• Must have failed positive airway pressure treatment (CPAP, BiPAP, etc.).
– Failure criteria
AHI >15 with usage Poor compliance of less than 4 hours per night 5 nights per week Unwillingness to use the device
• Do not have complete concentric velar collapse.
Contraindications:
• More than 25% of the apneas are central or mixed.
• Pregnant patients, or plan to become pregnant.
• Presence of other implanted devices that may interfere with the system.
• High BMI.
Major trial:
• STAR trial (stimulation therapy for apnea reduction)
– 126 patients with moderate-severe OSA and BMI <32 underwent UAS. – Median AHI decreased from 30 to 6, and 2/3 of participants were complete
responders.
– 86% reported excellent adherence.